The Food and Drug Administration has partnered with the Critical Path Institute and National Center for Advancing Translational Sciences to launch the CURE Drug Repurposing Collaboratory, a forum for exchanging clinical practice data to inform potential new uses for existing drugs to treat unmet medical needs, beginning with COVID-19.

CDRC will use data collected via the CURE ID platform to aggregate global clinician treatment experiences and identify existing drugs that demonstrate possible treatment approaches warranting further study.

Related News Articles

Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response June 26 at 1 p.m. ET will host the next webinar in…
Headline
The AHA today urged Congress to revise the Improving Medicare Post-Acute Care Transformation Act of 2014 in the next COVID-19 relief package to reflect new…
Headline
The Department of Health and Human Services today said its Office of Minority Health will partner with the Morehouse School of Medicine to deliver education…
Headline
Hospitalization rates for COVID-19 were nearly four times higher for black, and two times higher for Hispanic, Medicare beneficiaries than for white Medicare…
Headline
The House Energy and Commerce Committee today held a hearing on the administration’s response to the COVID-19 pandemic, which featured officials from the…
Headline
Beginning July 6, both traditional Medicare and Medicare Advantage plans will cover diagnostic COVID-19 laboratory tests for nursing home residents and…